Avalon BioVentures I, LP
10% Stockholder at JANX
- Sold, on record
- $45.8M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Sep 30, 2024
- Form 144 notices
- 11
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- JANXJanux Therapeutics, Inc.10% Stockholder
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice JANXNoticeSep 26, 2024 2024
Filed to sell 17,500 shares ($826k)
Avalon BioVentures I, LP, 10% Stockholder
No 10b5-1 planFiling
- 2 Form 144 notice JANXNoticeSep 27, 2024 +1 day
Filed to sell 9,187 shares ($427k)
Avalon BioVentures I, LP, 10% Stockholder
No 10b5-1 planFiling
- 3 Form 4 sale JANXUnusualSep 30, 2024 +3 days
Sold 307,779 shares at $46.96 ($14.5M)
Avalon BioVentures I, LP, 10% owner
No 10b5-1 planSold 97.8% of holdings ($14.8M position)6,887 shares leftFollows a Form 144Filing
- 4 Form 144 notice JANXNoticeOct 16, 2024 +16 days
Filed to sell 17,367 shares ($868k)
Avalon BioVentures I, LP, 10% Stockholder
No 10b5-1 plan0.1x usual sizeFiling
- 5 Form 144 notice JANXNoticeOct 18, 2024 +2 days
Filed to sell 22,895 shares ($1.2M)
Avalon BioVentures I, LP, 10% Stockholder
No 10b5-1 plan0.1x usual sizeFiling
- 6 Form 144 notice JANXNoticeOct 23, 2024 +5 days
Filed to sell 47,203 shares ($2.4M)
Avalon BioVentures I, LP, 10% Stockholder
No 10b5-1 plan0.2x usual sizeFiling
- 7 Form 144 notice JANXNoticeOct 25, 2024 +2 days
Filed to sell 32,800 shares ($1.7M)
Avalon BioVentures I, LP, 10% Stockholder
No 10b5-1 plan0.1x usual sizeFiling
- 8 Form 144 notice JANXNoticeNov 1, 2024 +7 days
Filed to sell 10,934 shares ($587k)
Avalon BioVentures I, LP, 10% Stockholder
No 10b5-1 plan0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Nov 1, 2024 | JANX | 10% Stockholder | Form 144 notice | 10,934 | $587k | Notice | SEC | |
| Oct 25, 2024 | Oct 25, 2024 | JANX | 10% Stockholder | Form 144 notice | 32,800 | $1.7M | Notice | SEC | |
| Oct 23, 2024 | Oct 23, 2024 | JANX | 10% Stockholder | Form 144 notice | 47,203 | $2.4M | Notice | SEC | |
| Oct 18, 2024 | Oct 18, 2024 | JANX | 10% Stockholder | Form 144 notice | 22,895 | $1.2M | Notice | SEC | |
| Oct 16, 2024 | Oct 16, 2024 | JANX | 10% Stockholder | Form 144 notice | 17,367 | $868k | Notice | SEC | |
| Sep 30, 2024 | Sep 30, 2024 | JANX | 10% owner | Form 4 sale | 307,779 | $14.5M | 97.8% | Unusual | SEC |
| Sep 27, 2024 | Sep 27, 2024 | JANX | 10% Stockholder | Form 144 notice | 9,187 | $427k | Notice | SEC | |
| Sep 26, 2024 | Sep 26, 2024 | JANX | 10% Stockholder | Form 144 notice | 17,500 | $826k | Notice | SEC | |
| Sep 12, 2024 | Sep 12, 2024 | JANX | 10% Stockholder | Form 144 notice | 30,613 | $1.4M | Notice | SEC | |
| Sep 12, 2024 | Sep 12, 2024 | JANX | 10% owner | Form 4 sale | 451,091 | $21.2M | 13.2% | No plan | SEC |
| Sep 10, 2024 | Sep 10, 2024 | JANX | 10% Stockholder | Form 144 notice | 8,842 | $402k | Notice | SEC | |
| Sep 9, 2024 | Sep 10, 2024 | JANX | 10% owner | Form 4 sale | 242,182 | $10.2M | 97.2% | Unusual | SEC |
| Sep 6, 2024 | Sep 6, 2024 | JANX | 10% Stockholder | Form 144 notice | 20,991 | $866k | Notice | SEC | |
| Jun 3, 2024 | Jun 3, 2024 | JANX | Director | Form 144 notice | 131,196 | $7.2M | Notice | SEC |